Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Cancer Cell International|April 19, 2019
Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progressionChia-Cheng Yu, Lih-Chyang Chen, Chih-Yung Chiou, et al.
Annals of Surgical Oncology|February 12, 2013
Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomyChi-Fen Chang, Jiunn-Bey Pao, Chia-Cheng Yu, et al.
International Journal of Medical Sciences|September 21, 2016
Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical ProstatectomyCheng-Hsueh Lee, Jiunn-Bey Pao, Te-Ling Lu, et al.
Oncotarget|November 2, 2017
Vitamin D receptor-binding site variants affect prostate cancer progressionVictor C Lin, Shu-Pin Huang, Huei-Ju Ting, et al.
The Chinese Journal of Physiology|January 6, 2017
Effect of thymol on Ca²⁺ homeostasis and viability in PC3 human prostate cancer cellsJeng-Hsien Yeh, Chiang-Ting Chou, I-Shu Chen, et al.
Environmental Toxicology and Pharmacology|October 13, 2014
Effect of melamine on [Ca(2+)]i and viability in PC3 human prostate cancer cellsChia-Cheng Yu, Chiang-Ting Chou, Te-Kung Sun, et al.
International Journal of Cancer|May 19, 2006
Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomyShu-Pin Huang, Chao-Yuan Huang, Wen-Jeng Wu, et al.
American Journal of Cancer Research|February 7, 2024
Identifying the role of MTHFD1L in prostate cancer progression from genetic analysis and experimental validationYuan-Chin Tsai, Shu-Pin Huang, Wei-Chung Cheng, et al.
Journal of Biochemical and Molecular Toxicology|June 3, 2016
Ca<sup>2+</sup> Signaling and Cell Death Induced by Protriptyline in HepG2 Human Hepatoma CellsJue-Long Wang, Chiang-Ting Chou, Kang Liu, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|May 28, 2011
Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapyShu-Pin Huang, Bo-Ying Bao, Ming-Tsang Wu, et al.
Pageof 10